Found: 40
Select item for more details and to access through your institution.
Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1463341
- By:
- Publication type:
- Article
Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084
- By:
- Publication type:
- Article
Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF<sup>V600E</sup>-Mutated Thyroid Cancer.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1270, doi. 10.4143/crt.2023.1278
- By:
- Publication type:
- Article
Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 6, p. 1, doi. 10.1007/s00520-023-07779-3
- By:
- Publication type:
- Article
Prognostic value of p21-activated kinase 4 in resected pancreatic cancer.
- Published in:
- APMIS, 2017, v. 125, n. 8, p. 699, doi. 10.1111/apm.12705
- By:
- Publication type:
- Article
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 721, doi. 10.4143/crt.2023.1043
- By:
- Publication type:
- Article
Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 567, doi. 10.4143/crt.2023.897
- By:
- Publication type:
- Article
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403
- By:
- Publication type:
- Article
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 61, doi. 10.4143/crt.2023.461
- By:
- Publication type:
- Article
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1104, doi. 10.4143/crt.2023.502
- By:
- Publication type:
- Article
Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 452, doi. 10.4143/crt.2022.910
- By:
- Publication type:
- Article
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 498, doi. 10.4143/crt.2022.388
- By:
- Publication type:
- Article
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344
- By:
- Publication type:
- Article
Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 344, doi. 10.4143/crt.2021.1603
- By:
- Publication type:
- Article
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 719, doi. 10.4143/crt.2021.1019
- By:
- Publication type:
- Article
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 630, doi. 10.4143/crt.2014.244
- By:
- Publication type:
- Article
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5450, doi. 10.3390/cancers15225450
- By:
- Publication type:
- Article
Trends in Survival Rates of Non–Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e232002, doi. 10.1001/jamanetworkopen.2023.2002
- By:
- Publication type:
- Article
Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8<sup>+</sup> T Cells.
- Published in:
- Advanced Science, 2023, v. 10, n. 17, p. 1, doi. 10.1002/advs.202204378
- By:
- Publication type:
- Article
Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7639, doi. 10.1002/cam4.5460
- By:
- Publication type:
- Article
Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 15, p. 2944, doi. 10.1002/cam4.4663
- By:
- Publication type:
- Article
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer.
- Published in:
- Pathology & Oncology Research, 2022, p. 01, doi. 10.3389/pore.2022.1610697
- By:
- Publication type:
- Article
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer.
- Published in:
- Radiation Oncology Journal, 2023, v. 41, n. 4, p. 274, doi. 10.3857/roj.2023.00773
- By:
- Publication type:
- Article
PD‐L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system.
- Published in:
- Histopathology, 2024, v. 84, n. 6, p. 1013, doi. 10.1111/his.15146
- By:
- Publication type:
- Article
Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early‐stage lung adenocarcinoma.
- Published in:
- Histopathology, 2023, v. 83, n. 2, p. 168, doi. 10.1111/his.14894
- By:
- Publication type:
- Article
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
- Published in:
- Biology (2079-7737), 2020, v. 9, n. 10, p. 326, doi. 10.3390/biology9100326
- By:
- Publication type:
- Article
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274830
- By:
- Publication type:
- Article
Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 367, doi. 10.1007/s11060-020-03617-2
- By:
- Publication type:
- Article
Prognostic significance of body mass index in small‐cell lung cancer: Exploring the relationship with skeletal muscle status.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2023, v. 14, n. 6, p. 2939, doi. 10.1002/jcsm.13345
- By:
- Publication type:
- Article
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1693, doi. 10.1002/cncr.35175
- By:
- Publication type:
- Article
Biomarker‐driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 4, p. 541, doi. 10.1002/cncr.35059
- By:
- Publication type:
- Article
A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 19, p. 2966, doi. 10.1002/cncr.34892
- By:
- Publication type:
- Article
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 11, p. 2148, doi. 10.1002/cncr.34176
- By:
- Publication type:
- Article
High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 16, p. 3019, doi. 10.1002/cncr.33571
- By:
- Publication type:
- Article
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0189766
- By:
- Publication type:
- Article